Upgrade to SI Premium - Free Trial

Compugen (CGEN)

2.59 +0.04 (1.57%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (11/16/26)

Latest Headlines

Daiichi Sankyo and AstraZeneca start phase 3 urothelial cancer trial August 26, 2026 7:00 AM - StreetInsider TROPION-Urothelial04 Phase 3 Trial of Datroway® Initiated as Adjuvant Therapy in Patients with High-Risk Muscle Invasive Urothelial Cancer August 26, 2026 7:00 AM - BizWire H.C. Wainwright Reiterates Buy Rating on Compugen (CGEN) August 4, 2026 6:53 AM - StreetInsider Form 6-K COMPUGEN LTD For: Aug 03 August 3, 2026 8:00 AM - SEC Filing Compugen (CGEN) Tops Q2 EPS by 1c August 3, 2026 7:21 AM - StreetInsider Form 6-K COMPUGEN LTD For: Jun 30 August 3, 2026 7:03 AM - SEC Filing Compugen Reports Second Quarter 2026 Results August 3, 2026 7:00 AM - PR NewsWire Form 4 COMPUGEN LTD For: Jul 29 Filed by: Levine Zurit July 30, 2026 4:14 PM - SEC Filing Form 4 COMPUGEN LTD For: Jul 29 Filed by: Silberman David July 30, 2026 4:11 PM - SEC Filing Form 4 COMPUGEN LTD For: Jul 29 Filed by: Ophir Eran July 30, 2026 4:10 PM - SEC Filing Form 4 COMPUGEN LTD For: Jul 29 Filed by: Cohen-Dayag Anat July 30, 2026 4:10 PM - SEC Filing Form 4 COMPUGEN LTD For: Jul 29 Filed by: Perry Eran July 30, 2026 4:09 PM - SEC Filing Form 4 COMPUGEN LTD For: Jul 29 Filed by: Ferre Pierre July 30, 2026 4:08 PM - SEC Filing Form 4 COMPUGEN LTD For: Jul 29 Filed by: Kredo Russo Sharon July 30, 2026 4:07 PM - SEC Filing Form 4 COMPUGEN LTD For: Jul 29 Filed by: Livnat Savitzky Kinneret July 30, 2026 4:06 PM - SEC Filing Form 4 COMPUGEN LTD For: Jul 29 Filed by: Hukkelhoven Mathias July 30, 2026 4:04 PM - SEC Filing Form 4 COMPUGEN LTD For: Jul 29 Filed by: Halevy Gilead July 30, 2026 4:03 PM - SEC Filing Form 4 COMPUGEN LTD For: Jul 29 Filed by: ZWEIFACH SANFORD S July 30, 2026 4:02 PM - SEC Filing Form 4 COMPUGEN LTD For: Jul 29 Filed by: Mahler Michelle July 30, 2026 4:01 PM - SEC Filing Compugen to Participate in BTIG Biotechnology Conference 2026 July 21, 2026 7:00 AM - PR NewsWire Compugen to Release Second Quarter 2026 Results on Monday, August 3, 2026 July 20, 2026 7:00 AM - PR NewsWire Form 4 COMPUGEN LTD For: Jul 09 Filed by: Levine Zurit July 13, 2026 4:02 PM - SEC Filing Compugen presents COM701 ovarian cancer trial poster at ESMO June 18, 2026 7:00 AM - StreetInsider Compugen Presents a Trial-in-Progress Poster on the MAIA-ovarian Adaptive Platform Trial at ESMO Gynaecological Cancers Congress June 18, 2026 7:00 AM - PR NewsWire Compugen to present ovarian cancer trial data at ESMO congress June 11, 2026 7:00 AM - StreetInsider Compugen to Present Phase 1 MAIA-Ovarian Trial-in-Progress Poster at ESMO Gynaecological Cancers Congress 2026 June 11, 2026 7:00 AM - PR NewsWire Form EFFECT COMPUGEN LTD June 9, 2026 6:05 AM - SEC Filing Compugen to Participate in Jones Trading Fireside Chat Series with Leaders in AI/ML-based Drug Development June 8, 2026 7:00 AM - PR NewsWire Full Article List